#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18694	16S	1529	1529	100.0	16S.l6.c30.ctg.1	1967	935.1	1	SNP	n	C1184T	0	.	.	1184	1184	C	1403	1403	C	1055	C	1032	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	147	18694	16S	1529	1529	100.0	16S.l6.c30.ctg.1	1967	935.1	0	HET	.	.	.	C207T,G,A	.	207	207	C	426	426	C	1084	C,T,G,A	807,223,1,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35026	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3592	968.0	0	.	n	.	0	T695C	SNP	695	695	T	1084	1084	C	1107	C,T	1085,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35026	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3592	968.0	0	.	n	.	0	A1638G	SNP	1638	1638	A	2027	2027	G	1048	G,A,T	780,247,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35026	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3592	968.0	0	.	n	.	0	T1971C	SNP	1971	1971	T	2360	2360	C	1123	C,A	1081,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35026	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3592	968.0	1	SNP	n	A2045G	0	.	.	2045	2045	A	2434	2434	A	1138	A	1114	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	35026	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3592	968.0	1	SNP	n	C2597T	0	.	.	2597	2597	C	2986	2986	C	1095	C,T	1072,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_O_01412c	folP.WHO_O_01412c	1	1	27	2516	folP	855	855	100.0	folP.l15.c4.ctg.1	1509	165.4	1	SNP	p	R229S	1	.	.	685	687	AGC	1031	1033	AGC	241;241;244	A;G;C	236;237;237	folP.WHO_O_01412c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7350	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3382	215.5	1	SNP	p	S91F	1	.	.	271	273	TTC	604	606	TTC	233;234;232	T;T;C,A	233;230;228,2	gyrA.WHO_M_01098:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7350	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3382	215.5	1	SNP	p	G95N	0	.	.	283	285	GGC	616	618	GGC	230;233;236	G;G;C	228;228;232	gyrA.WHO_M_01098:1:1:G95N:gyrA.95N:Resistance to fluoroquinolones	.
gyrA.WHO_M_01098	gyrA.WHO_M_01098	1	1	27	7350	gyrA	2751	2751	99.85	gyrA.l15.c4.ctg.1	3382	215.5	1	SNP	p	D95G	1	.	.	283	285	GGC	616	618	GGC	230;233;236	G;G;C	228;228;232	gyrA.WHO_M_01098:1:1:D95G:gyrA.95G:Resistance to fluoroquinolones	.
mtrR.WHO_V_01454	mtrR.WHO_V_01454	1	1	27	2174	mtrR	633	633	100.0	mtrR.l15.c30.ctg.1	1307	165.3	1	SNP	p	G45D	0	.	.	133	135	GGC	404	406	GGC	283;278;276	G;G,T;C,A,T	276;269,2;268,2,1	mtrR.WHO_V_01454:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	531	1156	mtrR_promoter	250	250	99.6	mtrR_promoter.l15.c4.ctg.1	956	119.6	0	.	n	.	0	A197.	DEL	197	197	A	547	547	A	272	A	266	.	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6068	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3062	196.6	1	SNP	p	D86N	0	.	.	256	258	GAC	692	694	GAC	224;224;224	G;A,G;C	217;210,2;217	parC.WHO_Y_00247c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6068	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3062	196.6	1	SNP	p	S87R	1	.	.	259	261	CGT	695	697	CGT	225;225;226	C;G;T	219;217;214	parC.WHO_Y_00247c:1:1:S87R:parC.87R:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6068	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3062	196.6	1	SNP	p	R87I	0	.	.	259	261	CGT	695	697	CGT	225;225;226	C;G;T	219;217;214	parC.WHO_Y_00247c:1:1:R87I:parC.87I:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6068	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3062	196.6	1	SNP	p	R87W	0	.	.	259	261	CGT	695	697	CGT	225;225;226	C;G;T	219;217;214	parC.WHO_Y_00247c:1:1:R87W:parC.87W:Resistance to fluoroquinolones	.
parC.WHO_Y_00247c	parC.WHO_Y_00247c	1	1	27	6068	parC	2304	2304	100.0	parC.l15.c4.ctg.1	3062	196.6	1	SNP	p	S88P	0	.	.	262	264	TCC	698	700	TCC	227;230;232	T;C;C,A	219;218;223,1	parC.WHO_Y_00247c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	5578	parE	1986	1986	100.0	parE.l15.c4.ctg.1	2650	208.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1542	1544	GGC	294;289;287	G;G;C	284;280;274	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.34.001	penA.34.001	1	1	27	5052	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2386	209.7	1	SNP	p	A311V	0	.	.	931	933	GCC	1361	1363	GCC	321;322;322	G,C;C;C	308,1;310;311	penA.34.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5052	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2386	209.7	1	SNP	p	I312M	1	.	.	934	936	ATG	1364	1366	ATG	322;323;326	A;T;G	311;310;314	penA.34.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5052	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2386	209.7	1	SNP	p	T316P	0	.	.	946	948	ACC	1376	1378	ACC	320;317;318	A;C;C,A	311;311;311,1	penA.34.001:1:1:T316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5052	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2386	209.7	1	SNP	p	V316T	1	.	.	946	948	ACC	1376	1378	ACC	320;317;318	A;C;C,A	311;311;311,1	penA.34.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5052	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2386	209.7	1	SNP	p	T483S	0	.	.	1447	1449	ACC	1877	1879	ACC	216;216;220	A,C;C;C,T,A	201,1;211;211,1,1	penA.34.001:1:1:T483S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5052	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2386	209.7	1	SNP	p	A501V	0	.	.	1501	1503	GCG	1931	1933	GCG	242;242;243	G;C,G;G	237;237,1;235	penA.34.001:1:1:A501V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5052	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2386	209.7	1	SNP	p	A501P	0	.	.	1501	1503	GCG	1931	1933	GCG	242;242;243	G;C,G;G	237;237,1;235	penA.34.001:1:1:A501P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5052	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2386	209.7	1	SNP	p	G542S	0	.	.	1624	1626	GGT	2054	2056	GGT	192;189;190	G;G;T	188;182;185	penA.34.001:1:1:G542S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5052	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2386	209.7	1	SNP	p	G545S	1	.	.	1633	1635	AGC	2063	2065	AGC	179;177;179	A,G;G;C,T	172,1;171;172,1	penA.34.001:1:1:G545S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.34.001	penA.34.001	1	1	27	5052	penA	1746	1746	100.0	penA.l15.c4.ctg.1	2386	209.7	1	SNP	p	P551S	0	.	.	1651	1653	CCG	2081	2083	CCG	146;146;146	C,G;C,G;G	131,2;133,2;121	penA.34.001:1:1:P551S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	7330	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3077	236.7	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1641	1643	CCG	246;244;247	C;C;G	229;232;223	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	3250	porA	1146	1146	99.91	porA.l15.c4.ctg.1	1786	180.4	0	.	p	.	0	M83fs	FSHIFT	247	247	A	556	556	C	211	C	196	.	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3416	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1330	249.5	1	SNP	p	G120K	1	.	.	358	360	AAG	529	531	AAG	244;245;248	A;A;G	237;240;231	porB1b.WHO_Y_02277c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3416	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1330	249.5	1	SNP	p	A121N	1	.	.	361	363	AAC	532	534	AAC	247;247;250	A;A;C,A	239;240;238,1	porB1b.WHO_Y_02277c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_Y_02277c	porB1b.WHO_Y_02277c	1	1	27	3416	porB1b	1038	1038	100.0	porB1b.l15.c17.ctg.1	1330	249.5	1	SNP	p	N121D	0	.	.	361	363	AAC	532	534	AAC	247;247;250	A;A;C,A	239;240;238,1	porB1b.WHO_Y_02277c:1:1:N121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_M_02157	rpoB.WHO_M_02157	1	1	27	12126	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4890	246.2	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1418	rpsJ	312	312	100.0	rpsJ.l15.c17.ctg.1	1056	132.9	1	SNP	p	V57M	1	.	.	169	171	ATG	576	578	ATG	280;280;279	A;T;G	274;275;273	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
